Susan is President and Head of U.S. Commercial at Bristol-Myers Squibb. Appointed to the role in October 2018, Susan has national oversight and financial responsibility of an organization delivering $12B in revenue annually. Susan leads more than 2,500 employees striving to bring to patients transformational medicines from the company’s oncology, cardiovascular, and immunoscience portfolios. Her role also encompasses engaging with health care policy and advocacy stakeholders, where her focus is on ensuring patients have affordable access to innovative medicines. Previously, Susan was the Senior Vice President and Head of Worldwide Commercialization at Bristol-Myers Squibb, a broad-scale global role where she led global brand teams; international access and pricing; and worldwide company and customer operations. Susan received a BA from Gettysburg College and an MPH from Columbia University Mailman School of Public Health.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.